Shigenori Homma

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi et al. · Cancer Immunology Immunotherapy · 2016 · 112 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma

Takahiro Einama, Hirofumi Kamachi, Hiroshi Nishihara et al. · Pancreas · 2011 · 110 citations

Medicine, Oncology, Pathology +16

IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells

Yujiro Toyoshima, Hidemitsu Kitamura, Huihui Xiang et al. · Cancer Immunology Research · 2019 · 96 citations · Full text

Medicine, Immunology, Oncology +17

Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer

Takahiro Einama, Shigenori Homma, Hirofumi Kamachi et al. · British Journal of Cancer · 2012 · 88 citations · Full text

Medicine, Oncology, Pathology +16

Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy

Yosuke Ohno, Yujiro Toyoshima, Hideaki Yurino et al. · Cancer Science · 2017 · 85 citations · Full text

Medicine, Immunology, Oncology +17